Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BTTXOTCMKTS:CVALFNYSE:UPHOTCMKTS:XCRT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTTXBetter Therapeutics$0.00$0.00$0.00▼$0.03$5K0.9517,283 shs1,000 shsCVALFCovalon Technologies$1.66-5.1%$1.78$1.46▼$3.08$45.51M0.544,089 shs800 shsUPHUpHealth$0.73$0.25▼$3.19$5.33M0.51121,201 shs348,700 shsXCRTXcelerate$0.02+16.6%$0.02$0.01▼$0.05$7.34M4.2462,287 shs120,300 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTTXBetter Therapeutics0.00%0.00%0.00%-75.00%-98.63%CVALFCovalon Technologies0.00%-2.47%-15.90%+3.75%+1.72%UPHUpHealth0.00%0.00%0.00%0.00%0.00%XCRTXcelerate0.00%-12.89%-15.08%-31.85%-26.20%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ACVALFCovalon TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AUPHUpHealthN/AN/AN/AN/AN/AN/AN/AN/AXCRTXcelerateN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBTTXBetter Therapeutics 0.00N/AN/AN/ACVALFCovalon Technologies 0.00N/AN/AN/AUPHUpHealth 0.00N/AN/AN/AXCRTXcelerate 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/ACVALFCovalon Technologies$22.91M1.99$0.10 per share16.93$0.74 per share2.24UPHUpHealth$153.15M0.00N/A0.18$7.05 per share0.00XCRTXcelerateN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBTTXBetter Therapeutics-$39.76MN/A0.00∞N/AN/AN/AN/A7/21/2025 (Estimated)CVALFCovalon Technologies$1.96M$0.0918.45∞N/A10.95%13.40%11.59%8/19/2025 (Estimated)UPHUpHealth-$223M-$4.50N/AN/AN/A-49.08%12.33%3.66%N/AXCRTXcelerateN/AN/A0.00∞N/AN/AN/AN/AN/ALatest XCRT, CVALF, UPH, and BTTX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/28/2025Q2 2025CVALFCovalon Technologies$0.01$0.01N/A$0.01$7.67 million$5.27 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBTTXBetter TherapeuticsN/AN/AN/AN/AN/ACVALFCovalon TechnologiesN/AN/AN/AN/AN/AUPHUpHealthN/AN/AN/AN/AN/AXCRTXcelerateN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBTTXBetter TherapeuticsN/AN/AN/ACVALFCovalon TechnologiesN/A8.396.09UPHUpHealthN/A0.130.13XCRTXcelerateN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBTTXBetter Therapeutics34.00%CVALFCovalon TechnologiesN/AUPHUpHealth23.35%XCRTXcelerateN/AInsider OwnershipCompanyInsider OwnershipBTTXBetter Therapeutics51.40%CVALFCovalon TechnologiesN/AUPHUpHealth41.27%XCRTXcelerateN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBTTXBetter Therapeutics4049.86 million24.23 millionOptionableCVALFCovalon TechnologiesN/A27.42 millionN/ANot OptionableUPHUpHealth61117.78 million10.44 millionOptionableXCRTXcelerate24434.45 millionN/ANot OptionableXCRT, CVALF, UPH, and BTTX HeadlinesRecent News About These CompaniesXcelerate Inc. (OTCMKTS:XCRT) Short Interest Down 81.7% in MayJune 14, 2025 | americanbankingnews.comXcelerate Inc. (XCRT) Stock Price, News, Quote & History - Yahoo FinanceJanuary 4, 2025 | finance.yahoo.comMichael F. O'SheaNovember 28, 2024 | wsj.comXcelerate, Inc. Announces FundingOctober 31, 2024 | accesswire.comXcelerate, Inc. Announces the Launch of the Ceramedx Tik Tok Skincare CampaignOctober 23, 2024 | accesswire.comXcelerate, Inc. Issues Shareholder UpdateOctober 15, 2024 | accesswire.comXcelerate, Inc. Announces Commencement of the Nationalization Process for its PCT International Patent ApplicationsAugust 23, 2024 | finance.yahoo.comXcelerate Inc XCRTAugust 15, 2024 | morningstar.comXcelerate, Inc. Releases Shareholder UpdateAugust 13, 2024 | accesswire.comXcelerate, Inc. Retains Investment Bank Craft Capital Management to Provide Investment Banking and Up-Listing Advisory ServicesJune 6, 2024 | accesswire.comXcelerate, Inc. Addresses Concerns About Recently Released Research ReportJune 4, 2024 | accesswire.comXcelerate, Inc. Announces Change of AuditorsMay 13, 2024 | accesswire.comXcelerate, Inc. Announces That It Has Filed Its 2023 Annual ReportApril 30, 2024 | accesswire.comXcelerate, Inc. Announces That ESN Group, Inc. Has Gone Live on the Army & Air Force Exchange Service Online ExchangeApril 25, 2024 | accesswire.comXcelerate, Inc. Engages Leading Investor Relations Firm Darrow Associates to Enhance Capital Markets PresenceMarch 25, 2024 | accesswire.comXcelerate, Inc. Announces Participation in The Microcap ConferenceJanuary 19, 2024 | finance.yahoo.comXcelerate, Inc. Announces Publication of its Two Utility Patent ApplicationsOctober 24, 2023 | finance.yahoo.comXcelerate, Inc. Announces that ESN Group, Inc. Has Been Approved as a Vendor to Army & Air Force Exchange ServiceSeptember 14, 2023 | stockhouse.comXcelerate, Inc. Announces that ESN Group, Inc. Has Been Approved as a Vendor to Army & Air Force Exchange ServiceSeptember 14, 2023 | finance.yahoo.comXcelerate, Inc.: Xcelerate Announces Marketing AgreementAugust 8, 2023 | finanznachrichten.deMedia Sentiment Over TimeXCRT, CVALF, UPH, and BTTX Company DescriptionsBetter Therapeutics NASDAQ:BTTX$0.0001 0.00 (0.00%) As of 06/20/2025 03:33 PM EasternBetter Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.Covalon Technologies OTCMKTS:CVALF$1.66 -0.09 (-5.14%) As of 06/20/2025 09:30 AM EasternCovalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity. It also offers medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides wound care dressings; surgical and peri-operative; and infection management products. It offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. The company serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.UpHealth NYSE:UPHUpHealth, Inc., together with its subsidiaries, operates as a digital health services company in the Americas, Europe, and Asia. The company operates through three segments Integrated Care Management, Virtual Care Infrastructure, and Services segments. The Integrated Care Management segment offers SyntraNet, an integrated health management platform that enables clinical and community-based care teams to share information, coordinate care, manage utilization, and improve health outcomes for individuals and populations. The Virtual Care Infrastructure segment provides the Martti platform, a digital health infrastructure that enables its partners to implement unique, private-label telehealth strategies customized to their specific needs and markets, including integrated telehealth and language access services. Its platform also offers telemedicine, such as telestroke, teleneurology, and telepsychiatry services. The Services segment offers behavioral health and pharmacy services, as well as operates HelloLyf CX platform for digital dispensary services and HelloLyf HX platform for digital hospital services; and provides diagnostic laboratory testing services. UpHealth, Inc. was founded in 2019 and is headquartered in Delray Beach, Florida.Xcelerate OTCMKTS:XCRT$0.02 +0.00 (+16.55%) As of 06/20/2025 03:28 PM EasternXcelerate Inc. acquires engineering/patents and applies to early-stage medical technology companies. The company engages in the formulation, packaging and marketing of consumer health and beauty, and clinically tested skin care products; development of artificial intelligence and virtual health technology to assist patients; owning and licensing the rights to various forms of medical equipment. It also provides Ceramedx, a natural plant based therapeutic skin care product; Earth Science Beauty, which offers natural facial skincare targeted to specific skin types. The company was formerly known as Union Dental Holdings, Inc. and changed its name to Xcelerate Inc. Xcelerate Inc. was incorporated in 1996 is based in Mauldin, South Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
